Search alternatives:
significantly improve » significantly improved (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
improve decrease » improve disease (Expand Search), improved urease (Expand Search), improves disease (Expand Search)
longer decrease » larger decrease (Expand Search), linear decrease (Expand Search)
Showing 101 - 120 results of 6,103 for search '(( significantly ((longer decrease) OR (largest decrease)) ) OR ( significantly improve decrease ))', query time: 0.50s Refine Results
  1. 101
    Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX

    Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …”
    Save to List
    Saved in:
  2. 102
    Summary of meta-analysis results to compare visfatin level before and after NSPT among cases with periodontitis.

    Summary of meta-analysis results to compare visfatin level before and after NSPT among cases with periodontitis. by Zahra Tajik (20752452)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 103
    List of Included studies.

    List of Included studies. by Zahra Tajik (20752452)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 104
    Flow chart of the literature search for studies included in meta-analysis.

    Flow chart of the literature search for studies included in meta-analysis. by Zahra Tajik (20752452)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 105
    The search strategy in three databases.

    The search strategy in three databases. by Zahra Tajik (20752452)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 106
    Summary of meta-analysis results to compare visfatin level before and after NSPT among cases with periodontitis and T2DM.

    Summary of meta-analysis results to compare visfatin level before and after NSPT among cases with periodontitis and T2DM. by Zahra Tajik (20752452)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 107
    The comparison of GCF visfatin level before and three months after NSPT among cases with periodontitis.

    The comparison of GCF visfatin level before and three months after NSPT among cases with periodontitis. by Zahra Tajik (20752452)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 108
    A summary of the included study characteristics.

    A summary of the included study characteristics. by Zahra Tajik (20752452)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 109
    NIH score.

    NIH score. by Zahra Tajik (20752452)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 110
    The comparison of saliva visfatin level before and three months after NSPT among cases with periodontitis.

    The comparison of saliva visfatin level before and three months after NSPT among cases with periodontitis. by Zahra Tajik (20752452)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 111
    The comparison of GCF visfatin level before and three months after NSPT among cases with periodontitis and T2DM.

    The comparison of GCF visfatin level before and three months after NSPT among cases with periodontitis and T2DM. by Zahra Tajik (20752452)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 112
    List of excluded studies.

    List of excluded studies. by Zahra Tajik (20752452)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 113
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  14. 114
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  15. 115
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  16. 116
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  17. 117
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  18. 118
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  19. 119
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  20. 120
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:

Search Tools: